DDX17 and breast carcinoma: Silencing of DDX17 expression significantly inhibits the expression of estrogen-dependent genes (e.g., pS2, Cathepsin D) and the estrogen-dependent growth of MCF-7 and ZR75-1 breast cancer cells.